↓ Skip to main content

Dove Medical Press

Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers

Overview of attention for article published in Drug Design, Development and Therapy, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
27 Mendeley
Title
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers
Published in
Drug Design, Development and Therapy, May 2014
DOI 10.2147/dddt.s58803
Authors

Emilio Clementi, Maria Vittoria Cossu, Dario Cattaneo, Serena Fucile, Sara Baldelli, Valeria Cozzi, Amedeo Ferdinando Capetti, Paolo Pellegrino

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 15%
Professor 4 15%
Researcher 4 15%
Other 2 7%
Student > Postgraduate 2 7%
Other 4 15%
Unknown 7 26%
Readers by discipline Count As %
Agricultural and Biological Sciences 6 22%
Medicine and Dentistry 5 19%
Sports and Recreations 2 7%
Biochemistry, Genetics and Molecular Biology 1 4%
Nursing and Health Professions 1 4%
Other 4 15%
Unknown 8 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2014.
All research outputs
#2,695,670
of 22,755,127 outputs
Outputs from Drug Design, Development and Therapy
#131
of 2,081 outputs
Outputs of similar age
#28,335
of 227,852 outputs
Outputs of similar age from Drug Design, Development and Therapy
#1
of 39 outputs
Altmetric has tracked 22,755,127 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,081 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,852 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.